Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05933070
Title A Phase I Open-Label Dose Escalation Study of Intravenous INKmune In Patients With MDS or AML (LAUREL)
Acronym LAUREL
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Inmune Bio, Inc.
Age Groups: senior | adult
Covered Countries GBR

No variant requirements are available.